326 related articles for article (PubMed ID: 20558550)
21. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene.
Peyrani P; Allen M; Wiemken TL; Haque NZ; Zervos MJ; Ford KD; Scerpella EG; Mangino JE; Kett DH; Ramirez JA;
Clin Infect Dis; 2011 Oct; 53(8):766-71. PubMed ID: 21880581
[TBL] [Abstract][Full Text] [Related]
22. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
[TBL] [Abstract][Full Text] [Related]
24. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
Honda H; Doern CD; Michael-Dunne W; Warren DK
BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
[TBL] [Abstract][Full Text] [Related]
25. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
26. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals.
Tadros M; Williams V; Coleman BL; McGeer AJ; Haider S; Lee C; Iacovides H; Rubinstein E; John M; Johnston L; McNeil S; Katz K; Laffin N; Suh KN; Powis J; Smith S; Taylor G; Watt C; Simor AE
PLoS One; 2013; 8(9):e75171. PubMed ID: 24069391
[TBL] [Abstract][Full Text] [Related]
28. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
[TBL] [Abstract][Full Text] [Related]
29. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
30. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China.
Chang W; Ma X; Gao P; Lv X; Lu H; Chen F
Indian J Med Microbiol; 2015; 33(2):262-6. PubMed ID: 25865979
[TBL] [Abstract][Full Text] [Related]
32. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
Bland CM; Porr WH; Davis KA; Mansell KB
South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
[TBL] [Abstract][Full Text] [Related]
34. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Gonzalez RP; Rostas J; Simmons JD; Allen J; Frotan MA; Brevard SB
Am J Surg; 2013 Mar; 205(3):255-8; discussion 258. PubMed ID: 23375761
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.
Rojas L; Bunsow E; Muñoz P; Cercenado E; Rodríguez-Créixems M; Bouza E
J Antimicrob Chemother; 2012 Jul; 67(7):1760-8. PubMed ID: 22556382
[TBL] [Abstract][Full Text] [Related]
36. Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia.
Pickens CI; Wunderink RG
Semin Respir Crit Care Med; 2022 Apr; 43(2):304-309. PubMed ID: 35170002
[TBL] [Abstract][Full Text] [Related]
37. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.
van Hal SJ; Lodise TP; Paterson DL
Clin Infect Dis; 2012 Mar; 54(6):755-71. PubMed ID: 22302374
[TBL] [Abstract][Full Text] [Related]
39. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Quartin AA; Scerpella EG; Puttagunta S; Kett DH
BMC Infect Dis; 2013 Nov; 13():561. PubMed ID: 24279701
[TBL] [Abstract][Full Text] [Related]
40. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia.
Zhang Y; Wang Y; Van Driel ML; McGuire TM; Zhang T; Dong Y; Liu Y; Liu L; Hao R; Cao L; Xing J; Dong Y
Antimicrob Resist Infect Control; 2019; 8():72. PubMed ID: 31080587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
